GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Pharma Holding Inc (STU:XQJ0) » Definitions » Cyclically Adjusted PB Ratio

China Pharma Holding (STU:XQJ0) Cyclically Adjusted PB Ratio : 0.01 (As of Jun. 07, 2024)


View and export this data going back to 2009. Start your Free Trial

What is China Pharma Holding Cyclically Adjusted PB Ratio?

As of today (2024-06-07), China Pharma Holding's current share price is €2.68. China Pharma Holding's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €372.87. China Pharma Holding's Cyclically Adjusted PB Ratio for today is 0.01.

The historical rank and industry rank for China Pharma Holding's Cyclically Adjusted PB Ratio or its related term are showing as below:

STU:XQJ0' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.01   Med: 0.12   Max: 0.53
Current: 0.01

During the past years, China Pharma Holding's highest Cyclically Adjusted PB Ratio was 0.53. The lowest was 0.01. And the median was 0.12.

STU:XQJ0's Cyclically Adjusted PB Ratio is not ranked
in the Drug Manufacturers industry.
Industry Median: 1.88 vs STU:XQJ0: 0.01

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

China Pharma Holding's adjusted book value per share data for the three months ended in Mar. 2024 was €0.515. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €372.87 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


China Pharma Holding Cyclically Adjusted PB Ratio Historical Data

The historical data trend for China Pharma Holding's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Pharma Holding Cyclically Adjusted PB Ratio Chart

China Pharma Holding Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.10 0.21 0.27 0.07 0.01

China Pharma Holding Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.03 0.01 0.01 0.01

Competitive Comparison of China Pharma Holding's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, China Pharma Holding's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Pharma Holding's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Pharma Holding's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where China Pharma Holding's Cyclically Adjusted PB Ratio falls into.



China Pharma Holding Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

China Pharma Holding's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=2.68/372.87
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Pharma Holding's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, China Pharma Holding's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.515/115.2271*115.2271
=0.515

Current CPI (Mar. 2024) = 115.2271.

China Pharma Holding Quarterly Data

Book Value per Share CPI Adj_Book
201406 102.134 98.200 119.843
201409 102.080 98.900 118.932
201412 86.293 99.000 100.437
201503 104.705 99.900 120.769
201506 97.116 99.500 112.466
201509 88.747 100.500 101.752
201512 76.508 100.600 87.632
201603 73.738 102.200 83.137
201606 68.375 101.400 77.699
201609 66.381 102.400 74.696
201612 64.074 102.600 71.960
201703 62.673 103.200 69.977
201706 58.350 103.100 65.213
201709 54.899 104.100 60.767
201712 41.757 104.500 46.043
201803 41.362 105.300 45.261
201806 40.291 104.900 44.258
201809 37.002 106.600 39.997
201812 30.456 106.500 32.952
201903 31.088 107.700 33.261
201906 29.414 107.700 31.470
201909 28.500 109.800 29.909
201912 9.539 111.200 9.884
202003 8.701 112.300 8.928
202006 8.557 110.400 8.931
202009 7.655 111.700 7.897
202012 7.218 111.500 7.459
202103 6.603 112.662 6.753
202106 5.941 111.769 6.125
202109 6.154 112.215 6.319
202112 5.625 113.108 5.730
202203 5.020 114.335 5.059
202206 3.861 114.558 3.884
202209 2.837 115.339 2.834
202212 2.703 115.116 2.706
202303 2.581 115.116 2.583
202306 1.758 114.558 1.768
202309 0.997 115.339 0.996
202312 0.643 114.781 0.645
202403 0.515 115.227 0.515

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


China Pharma Holding  (STU:XQJ0) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


China Pharma Holding Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of China Pharma Holding's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


China Pharma Holding (STU:XQJ0) Business Description

Traded in Other Exchanges
Address
Second Floor, No. 17, Jinpan Road, Hainan Province, Haikou, CHN, 570216
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.

China Pharma Holding (STU:XQJ0) Headlines

No Headlines